Searched for
RIVASTIGMINE CAPSULES
China halts sale of Sun Pharma drug used to treat dementiaChina's medicine regulator has halted the import, sale, and use of Sun Pharmaceutical Industries' dementia drug, rivastigmine hydrogen tart...- Aurobindo Pharma gets final USFDA nod for dementia drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Rivastigmine Tartrate Capsules USP.
- Dr Reddy's recalls Rivastigmine Tartrate capsules of 1.5 mg strength from USDr Reddy's Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market.
- Orchid Chemicals surges 16% on USFDA approval for Gemifloxacin MesylateThe company is present in segments like anti-infective, anti-inflammatory, central nervous system, cardio vascular segment and other oral a...
- Sensex up over 150 points, Nifty tests 8,000; Sun TV surges 10%The 50-share Nifty index recovered losses and is trading above its crucial psychological level of 8,000.
- Twelve stocks in focus in Monday's tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.
- Orchid Chemicals gets USFDA nod for two generic drugsThe nod was for generic Rivastigmine capsules and Felodipine extended release tablets aimed at treating mild to moderate dementia and hyper...
- Alembic Pharmaceuticals soars on patent settlement case with NovartisShares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
- DRL, Novartis smoke peace pipe on Alzheimer's drugDr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastig...
- DRL gets tentative USFDA nod for Alzheimer's drugDr Reddy's Laboratories Ltd has received tentative approval from the USFDA for the drug 'Rivastigmine' in capsule form.
Load More
